Dysarthria is a motor speech disorder caused by neurological injury or disease that weakens or disrupts the coordination of muscles used for speech. Unlike language or fluency disorders, dysarthria impairs the execution of speech movements, often resulting in slurred, strained, or breathy speech. It may affect one or more subsystems of speech—respiration, phonation, resonance, articulation, or prosody—leading to reduced intelligibility. The severity can range from mild distortion to speech that is unintelligible and requires augmentative communication.
Clinically, dysarthria is classified into subtypes based on lesion location and speech characteristics. These include flaccid, spastic, ataxic, hypokinetic, hyperkinetic, and mixed dysarthrias, each with distinct features and neurological origins. For example, spastic dysarthria produces slow, strained speech, while ataxic dysarthria is marked by slurred articulation and erratic rhythm. Although dysarthria affects how speech is produced, it does not imply deficits in language or cognition unless co-occurring conditions are present.
Dysarthria can result from any condition that disrupts the motor pathways controlling speech. Major causes include:
1. Stroke (Cerebrovascular Accidents): Strokes affecting the brain’s motor regions or brainstem can cause dysarthria by impairing upper or lower motor neurons. Unilateral cortical strokes may cause mild articulatory slurring, while bilateral strokes often lead to spastic dysarthria with strained, slow speech. Brainstem strokes can damage cranial nerve nuclei, resulting in flaccid dysarthria with hypernasality, breathiness, or mixed presentations.
2. Neurodegenerative Diseases: Progressive conditions like Parkinson’s disease, ALS, and MS frequently produce dysarthria. Parkinson’s leads to hypokinetic dysarthria marked by low volume, monotone voice, and blurred articulation. ALS causes mixed spastic-flaccid dysarthria, while MS and Huntington’s disease result in mixed or spastic-ataxic speech features, depending on the affected neural systems.
3. Traumatic Brain Injury (TBI): TBI can cause both focal and diffuse brain damage that affects speech control. Depending on injury location, dysarthria may be spastic, ataxic, flaccid, or mixed. Contusions, axonal injury, or cranial nerve involvement (from skull fractures or penetrating trauma) all contribute to speech impairments post-TBI.
4. Cerebral Palsy: In children, cerebral palsy often leads to developmental dysarthria due to early brain damage. Spastic and hyperkinetic types are most common, resulting in strained or variably distorted speech. Severity ranges from mild slurring to profound unintelligibility, with some individuals requiring AAC.
5. Peripheral Nervous System Damage: Damage to cranial nerves involved in speech—due to injury, tumors, or conditions like Bell’s palsy—can produce flaccid dysarthria. Vagus nerve involvement may cause hoarseness and resonance issues, while hypoglossal nerve damage impairs lingual articulation. Myasthenia gravis causes fatigable weakness, leading to speech deterioration during extended talking.
6. Other Causes: Infections (e.g., encephalitis, polio), toxic-metabolic disorders (e.g., drug overdose, hepatic encephalopathy), and neurosurgical complications can all produce dysarthria. These conditions may cause temporary or lasting speech deficits depending on the extent of neural involvement. Identifying the cause helps guide treatment and often aids in neurological localization.
Speech-language pathologists play a critical role in managing dysarthria by improving speech intelligibility, optimizing communication effectiveness, and providing alternative communication methods when necessary. Therapy is tailored to individual deficits—breath support may be addressed through respiratory training, phonation through techniques like LSVT LOUD, and articulation through strategies such as slowed speech and over-articulation. Resonance and prosody are targeted with specific techniques, ranging from biofeedback tools to prosthetic support for velopharyngeal dysfunction. When speech remains severely impaired, SLPs introduce augmentative and alternative communication (AAC) systems, including both low- and high-tech solutions.
SLPs also train caregivers and listeners to support communication through strategies like environmental modifications and alphabet supplementation. In progressive conditions such as ALS or Parkinson’s, therapy goals may shift from speech restoration to compensatory support and end-of-life communication planning. Collaboration with medical professionals is often essential, particularly when pharmacologic or surgical treatments complement therapy (e.g., dopamine therapy in Parkinson’s or Botox in dystonia). Overall, SLPs serve as diagnosticians, therapists, and communication engineers—helping individuals with dysarthria maintain their voice, autonomy, and connection to others.
Duffy, Joseph R. Motor Speech Disorders: Substrates, Differential Diagnosis, and Management, 4th ed. St. Louis: Elsevier, (2020).
Kent, Raymond D., and Barbara Weismer. “Speech Production in Neurological Disorders.” In Handbook of Speech and Language Disorders, edited by J.R. Duffy, 219–245. New York: Thieme, (2013).
Lowit, Anja, and Raymond D. Kent. “Management of Dysarthria.” In Aphasia and Related Neurogenic Communication Disorders, edited by Ilias Papathanasiou and Patrick Coppens, 527–556. Burlington, MA: Jones & Bartlett, (2011).
Yorkston, Kathryn M., and Deanna H. Beukelman. Assessment of Intelligibility of Dysarthric Speech. Austin, TX: Pro-Ed, (1981).
